Golden State Medical Supply Inc.: Drug Recall

Recall #D-1177-2022 · 03/16/2022

Class II: Risk

Recall Details

Recall Number: D-1177-2022
Classification: Class II
Product Type: Drug
Recalling Firm: Golden State Medical Supply Inc.
Status: Ongoing
Date Initiated: 03/16/2022
Location: Camarillo, CA, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,471 bottles

Reason for Recall

CGMP Deviations

Product Description

Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.

Distribution Pattern

Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI

Other Recalls by Golden State Medical Supply Inc.

Class II: Risk 11/26/2025

Presence of Foreign Tablets/Capsules
Class II: Risk 10/20/2025

Failed Dissolution Specifications
Class II: Risk 03/05/2025

Failed Dissolution Specifications
Class II: Risk 05/13/2024

CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Class II: Risk 02/14/2024

CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex

View all recalls by Golden State Medical Supply Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.